<--- Back to Details
First PageDocument Content
Medicine / Antithrombin / Biotechnology / Pharmacology / Pulmonary embolism / Thrombus / Recombinant DNA / Thrombin / Biologic / Biology / Blood / Coagulation system
Medicine
Antithrombin
Biotechnology
Pharmacology
Pulmonary embolism
Thrombus
Recombinant DNA
Thrombin
Biologic
Biology
Blood
Coagulation system

Recommendation to grant GTC Biotherapeutics request

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 34,69 KB

Share Document on Facebook

Similar Documents

Large ElectronPositron Collider

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document